JOINN (603127.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec1

Multiple Executives of ZhaoYan New Drug Completed their Stock Sale Plans

10:14

Nov27

Director Sun Yunxia of Zhaoyan New Drug Reduces 100,000 Shares

12:03

Nov14

Directors of Zhaoyan New Drug Reduced Shares

12:03

Nov13

Huaxi Securities Maintains '增持' Rating for Zhaoyan Pharmaceutical, Predicts Future Demand Improvement

06:44

Nov4

Executives of Syneos Health China Cut Shares Held

12:04

Oct30

JOINN released FY2025 9 Months Earnings on October 30 During-Market (BJT) with actual revenue of CNY 984.96 M and EPS of CNY 0.1074

01:00

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 316.39 M, Net Income 19.77 M, EPS 0.0291

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 381.24 M, Net Income 19.81 M, EPS 0.0282

Aug14

Distribution Plan(CST)

Cash dividend 0.03 CNY

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More